Australia markets closed

Fuji Pharma Co., Ltd. (FUP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.40+0.35 (+3.87%)
At close: 08:10AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
43,052,000
40,889,000
35,426,000
33,990,000
33,793,000
Cost of revenue
25,927,000
24,374,000
20,867,000
19,239,000
18,921,000
Gross profit
17,124,000
16,514,000
14,558,000
14,751,000
14,872,000
Operating expenses
Research development
-
3,184,000
2,485,000
2,446,000
3,060,000
Selling general and administrative
-
-
-
1,345,000
1,489,000
Total operating expenses
13,642,000
12,652,000
10,777,000
11,402,000
11,728,000
Operating income or loss
3,482,000
3,862,000
3,781,000
3,349,000
3,144,000
Interest expense
138,000
107,000
77,000
53,000
37,000
Income before tax
7,970,000
4,399,000
3,723,000
3,371,000
2,918,000
Income tax expense
2,050,000
963,000
1,026,000
938,000
832,000
Income from continuing operations
5,920,000
3,436,000
2,697,000
2,433,000
2,086,000
Net income
5,920,000
3,435,000
2,696,000
2,432,000
2,085,000
Net income available to common shareholders
5,920,000
3,435,000
2,696,000
2,432,000
2,085,000
Basic EPS
141.37
141.37
111.01
90.54
66.94
Diluted EPS
141.37
141.37
111.01
90.54
66.94
Basic average shares
24,301
24,301
24,293
26,867
31,157
Diluted average shares
24,303
24,301
24,293
26,867
31,157